Synthesia was co-founded by researchers at UCL, Stanford, Cambridge and TUM to build a platform that generates video content using artificial intelligence.

UPMC Enterprises has co-led a seed round for the gene therapy developer.

Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.

University of Sheffield spinout Rinri Therapeutics has collected $13.9m from investors including Boehringer Ingelheim Venture Fund and UCB Ventures.

Tectonic Therapeutic is the latest venture undertaken by Harvard’s serial entrepreneur Timothy Springer, who co-led the series A round.

Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.

MaC Venture Capital has raised its inaugural seed fund thanks to limited partners including University of Michigan and Howard University.

Ocado will provide $13.8m in a series B extension that follows a $47m close in January.

UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.

Originally known as Cambridge Crops, the MIT and Tufts-linked company has added $16m to its coffers.